Phase 3 study of carboplatin-paclitaxel/nab-paclitaxel (Chemo) with or without pembrolizumab (Pembro) for patients (Pts) with metastatic squamous (Sq) non-small cell lung cancer (NSCLC).-MedSci.cn

Phase 3 study of carboplatin-paclitaxel/nab-paclitaxel (Chemo) with or without pembrolizumab (Pembro) for patients (Pts) with metastatic squamous (Sq) non-small cell lung cancer (NSCLC).

Paz-Ares, LG; Luft, A; Tafreshi, A; Gumus, M; Mazieres, J; Hermes, B; Senler, FC; Fulop, A; Rodriguez-Cid, J; Sugawara, S; Cheng, Y; Novello, S; Halmos, B; Yue, ST; Kowalski, D

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (15):

科室
- - 订阅+
  - 更多科室
工具
服务